NCT06535568
- Conditions
- Acute Coronary Syndrome, Antineoplastic Agents, Arterial Occlusive Diseases, +23 more
- Locations
-
- IRCCS Auxologico Milano Milan, MI, Italy
Clinical trial condition
Protein Kinase Inhibitors
Explore clinical trials studying Protein Kinase Inhibitors. Study availability and eligibility vary by location and protocol.
5 public trials
2 recruiting studies
Protein Kinase Inhibitors trial results
NCT06128148
- Conditions
- Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +12 more
- Locations
-
- Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China
NCT04518852
- Conditions
- Adenocarcinoma, Antineoplastic Agents, Carcinoma, +13 more
- Locations
-
- Sichuan Cancer Hospital and Research Institute Chengdu, Sichuan, China
NCT00676299
- Conditions
- Advanced Malignancies, Antineoplastic Protocols, Clinical Trial, Phase 1, +4 more
- Locations
-
Not specified
Active, Not Recruiting
Savolitinib vs. Sunitinib in MET-driven PRCC.
NCT03091192
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Research Site La Jolla, California, United States
- Research Site Atlanta, Georgia, United States
- Research Site Chicago, Illinois, United States
- Research Site Iowa City, Iowa, United States